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A critical synthesis of the role of the pharmacist in oral
healthcare and management of medication-related
osteonecrosis of the jaw
A. Sturrock 1, P. M. Preshaw2,3, C. Hayes1,4 and S. Wilkes1
OBJECTIVE: To consolidate extant published evidence in relation to the potential of integrating oral healthcare for patients at risk
of developing medication-related osteonecrosis of the jaw (MRONJ).
METHODS: A critical synthesis and consolidation of five publications was undertaken. As a mechanism of situating the extant work
within the context of primary healthcare provision, the Rainbow Model of Integrated Care was applied as a theoretical lens through
which the conceptual findings could be collectively applied to practice.
RESULTS: The critical synthesis revealed a thematic emergence relating to both formative and normative integration. The most
salient of these were the identification of limited shared clinical records, and disconnection of oral healthcare provision from
patients’ general medical care. The three levels of the Rainbow Model of Integrated Care reflected a series of issues for address.
CONCLUSION: In the context of collaborative, multi-disciplinary working for patients at risk of development of MRONJ, pharmacists
are a professional group which this research reveals to be an underutilised resource. Reduction of oral health inequality at all levels
of patient care is a key priority and this research highlights areas for address in relation to requirements for interprofessional
education, optimal communication and policies reflective and facilitative of these.
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INTRODUCTION
The provision of preventive oral healthcare advice has traditionally
been the preserve of dental health professionals; a situation that
has been established over the years as a result of the differing
training, clinical practice and healthcare delivery systems that exist
between dental care and other aspects of healthcare. However,
over recent years there has been increasing recognition of the
links between oral health and a number of systemic diseases and
conditions, as exemplified by the relationships that have been
identified between periodontitis and cardiovascular disease and,
most notably, type 2 diabetes.1–4
Wilson and Soni, the former presidents of the British Dental
Association and Royal Pharmaceutical Society, respectively, in
2016 published an opinion piece in the British Dental Journal;
emphasising the opportunities for pharmacy and dentistry to
spearhead a new era of interprofessional healthcare.5 The existing
literature highlights a potential role for pharmacists in the
provision of oral healthcare; a number of studies have identified
that patients already attend pharmacies for advice in relation to
oral health concerns and that pharmacists agree that the provision
of oral healthcare is part of their role.6–8 However, studies have
demonstrated that pharmacists have limited awareness of the
links between oral and systemic health.9 There is also minimal
existing published literature exploring the relationship and
integration between pharmacy and dental service providers, with
evidence highlighting a lack of communication and collaboration,
despite there being a positive interest in developing collaborative
relationships.10,11
There is also a lack of published literature on the role of
pharmacists in relation to the oral health-related adverse effects of
medications. One such condition is medication-related osteone-
crosis of the jaw (MRONJ), which represents a significant adverse
effect of a range of anti-resorptive and anti-angiogenic drugs,
such as the bisphosphonates and denosumab. MRONJ is a
complex phenomenon and due to the significant morbidity of
the condition and the limited treatment options available for its
address, the elimination or stabilisation of oral disease before
initiating implicated medications is recommended as a preventa-
tive measure.12
MRONJ is relatively rare, the estimated incidence of MRONJ in
cancer patients treated with anti-resorptive or anti-angiogenic
drugs is 1% and in osteoporosis patients treated with anti-
resorptive drugs is 0.01–0.1%.12 Therefore, whereas pharmacists
are unlikely to encounter patients with MRONJ regularly in
practice, they do have close and frequent contact with patients
prescribed implicated medications.
Current guidelines published by the Scottish Dental Clinical
Effectiveness Programme recommend an interprofessional
approach to the prevention of MRONJ.12 This clearly represents
an opportunity for pharmacists, in all settings, to engage with
this patient group and provide education to patients and
other members of the interprofessional healthcare team on the
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risk of the development of MRONJ and appropriate preventive
measures.
Accordingly, in this study, we sought to investigate the
integration of oral health promotion and advice regarding the
prevention of MRONJ into the role of pharmacists.
METHODS
A series of five independent studies were undertaken by the
authors of this paper.13–17 This body of published work
contributes to the investigation of MRONJ, and the role of
pharmacists in both MRONJ prevention and oral health promo-
tion; which are fields that remain largely underreported in the
extant literature. In this paper we present a critical synthesis of
these five previously published papers, which substantively
integrates the findings of the published work. This was under-
taken via a theoretical lens which was conceptually appropriate to
the context of care, the Rainbow Model for Integrated Care.18
Three of the published studies explored the interprofessional
prevention of MRONJ through qualitative semi-structured inter-
views with pharmacists,13 general medical practitioners (GPs),13
general dental practitioners (GDPs)15 and patients.14 The fourth
study explored the integration of oral healthcare advice into the
role of clinical pharmacists working in general medical practice.16
An interpretive qualitative approach was adopted in each of these
four studies, with constant comparative analysis facilitating an
iterative process of data collection and analysis.19 Semi-structured
interviews and focus groups were transcribed verbatim and
framework analysis facilitated the prioritisation of salient
themes.20 A total of 77 participants were interviewed across these
four studies; 19 pharmacists, 11 GPs, 15 GDPs, 29 patients, 2
nurses and 1 practice manager. The fifth study piloted the
provision of a brief oral health promotion intervention to 1069
patients in community pharmacies in County Durham, UK.17
The Rainbow Model of Integrated Care was originally designed
to facilitate clinicians and researchers in achieving a better
understanding of the concept of integrated care from a primary
care perspective.18 It has been applied to a range of studies,
including qualitative and survey-based research and systematic
reviews.21–24 This conceptual framework was adopted in this study
as a theoretical lens through which the barriers to, and facilitators
of, integrating MRONJ prevention and oral healthcare into the role
of the pharmacist could be explored in practice. Themes from
each individual study were used as a mechanism of collective
guidance in the initial critical synthesis. During this process, the
original raw data in the form of verbatim transcripts were
collectively revisited and reanalysed via the theoretical lens of
the Rainbow Model of Integrated Care.
Central to the model is the co-ordination of concepts into three
dimensions that capture the individual complexity and inter-
dependent elements of collaborative healthcare alongside the
various forms of integration required for optimal levels of person-
centred and population-focused healthcare.
Macro: external structural, social and regulatory issues which are
beyond the control of the individual or influence of individual
organisations.
Meso: local community and institutional factors and influences.
Micro: day-to-day practices of individuals and their practice
environments.
Person-focused healthcare is based around the premise that
diseases are simultaneously medical, psychological and social
problems, with mechanisms of care provision based on personal
preferences, needs and values. Population-based healthcare
indicates that services should be designed and delivered in line
with the needs and characteristics of a defined population as well
as their expressed preferences.18
The Rainbow Model of Integrated Care was produced as a
means of visually conceptualising each of these components of
integrated care (Fig. 1). Central to the model is the individual
patient, visualised through the concept of patient-focused care
and processes of clinical integration. At a meso level, both
professional and organisational integration emphasise a
population-based approach. At a macro level, systems integration
places the patient at the centre of the healthcare system,
embracing the premise that what is best for the individuals
within a defined population is also best for the population as a
whole.18 Both vertical and horizontal integration are fundamental
components of systems integration. Vertical integration includes
strategies which link the various levels and degrees of specialised
care within and between sectors; this includes integration of
Fig. 1 Rainbow Model of Integrated Care.18 The model is a means of visually framing the concept of clinical integration, in the context of
patient centred care. The liminal levels represented at macro, meso and micro levels provide an insight into the population-based approaches
adopted and how these are effectively translated into practice at macro and, consequently, micro levels.
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services from a primary care perspective, with both secondary and
tertiary care settings. Horizontal integration takes a more holistic
view and includes strategies which link similar levels of care across
sectors, and acts to improve the health of individual patients and
populations.18
Valentijn et al.18 describe a range of other forms of integration
that are required for effective collaborative and integrated care at
the meso (organisational and professional integration) and micro
level (clinical integration). Functional and normative integration
also link the micro, meso and macro dimensions of the healthcare
system.18
Ethics
Formal ethical approval for each of the studies selected for
inclusion in this critical synthesis had previously been granted by
the University of Sunderland Ethics Committee.
RESULTS
A range of barriers to, and facilitators of, MRONJ prevention and
oral healthcare integration into the role of the pharmacist was
identified and aligned to the constructs of the Rainbow Model for
Integrated Care. Direct qualitative quotes from verbatim tran-
scripts of interviews are included in Table 1 as a means of
illustrating the integration of findings from across the original
research studies undertaken.
Macro (system integration)
NHS policy and dental care services. Participants reported that
dental care services in the UK have traditionally placed limited
emphasis on preventive dental care (Quote 1, Q1); a situation that
has likely arisen, at least in part, from remuneration systems that
have rewarded interventions to deal with the consequences of
dental diseases rather than their prevention. Although new
methods of care delivery that prioritise prevention are currently
being piloted in the UK, they have yet to be implemented at scale.
Prevention is particularly important when considering the
management of MRONJ, as good oral hygiene and preventive
dental treatment can significantly reduce the risk of developing
the condition.
There is an identifiable need for the system to facilitate an
increased emphasis on engaging patients and other healthcare
professionals with mechanisms of oral health promotion and
preventive care; this relates to the education of patients and to the
structure and funding of dental services. NHS dental care in
England requires that the majority of adult patients must pay a
proportion of the cost of their dental treatment (akin to ‘co-
payments’); however, for some people on low incomes, they are
exempt from all charges. The requirement for individuals to pay a
proportion of the costs was described as a significant barrier by
both patients and healthcare professionals to the engagement of
certain sectors of the population in regular preventative dental
care and intervention (Q2). Supportive and prevention-based oral
healthcare policies could potentially facilitate enhanced levels of
engagement of both patients and healthcare professionals in
attending and facilitating oral healthcare, respectively.
Education of patients and preconceptions. Oral health education
for patients is typically only provided in a dental setting (Q3). This
strengthens the long-held assumptions of dental and medical
services as being disciplinary silos, which, in turn, acts as a barrier
to the full integration of dental and general healthcare. A
commonly identified theme is the phobia of dental treatments
reported by many patients (Q2). A move to preventive dental care
to reduce the need for invasive dental treatment has the potential
to engage more patients with oral healthcare and, as a
consequence, enable timely intervention and advice.
There is also a need for patient education on what the roles of
the healthcare team constitute; pharmacists were recognised as
good sources of healthcare information, but there has historically
been limited engagement with oral health advice as part of their
role. The patients interviewed in this work described growing up
with healthcare professionals undertaking stereotypical traditional
roles, with little evidence of dental education forming part of any
contact with healthcare professionals other than dentists (Q3, Q4).
In order to fully engage the public with oral health, the relative
degree of abstraction and physical isolation of dental care from
general health and well-being services needs to be addressed so
that it can be better integrated into the interprofessional team
and serve to challenge society’s often misplaced preconceptions
and presuppositions about practices and processes of dental care.
The positive response of patients towards our intervention piloted
in County Durham found that very few patients receiving the
intervention considered that a pharmacy was not an appropriate
place to receive advice about their teeth (3%);17 demonstrating
the acceptability to patients of pharmacy’s increased role in the
provision of oral healthcare.
Meso (organisational/professional integration)
Isolation. All professional groups interviewed in these works
cited the perception of poor working relationships between dental
and medical services and isolated practices, both at an individual
clinical level and at an organisational and professional level (Q5).
This included both the situational and geographical isolation of
dental services, which is further exacerbated by limited referral
pathways between the settings and a reportedly minimal degree
of interprofessional education. The lack of locally commissioned
collaborative services represents a clear barrier; however, our work
has shown that when oral health teams and pharmacy do
collaborate, positive contributions at both the levels of population
and individual patient health can be achieved. Following our pilot
pharmacy-based oral health intervention, 66% of patient partici-
pants stated that they definitely intended to change the way that
they looked after their teeth.17
Communication and collaboration. A significant challenge for the
integration of dental and general medical care is the currently
limited communication and collaboration evident between these
care settings. Pharmacy and medical participants reported good
lines of communication between their respective services, with
pharmacists increasingly contributing to more advanced clinical
services in both community and general practice settings (Q6).
This was facilitated through close reciprocal interprofessional
education, formal referral pathways and shared access to either
full medical records (in the case of general practice pharmacists)
or Summary Care Records. Such lines of communication and
collaboration between primary care dental services and phar-
macy/medical services do not exist, posing a significant barrier for
the integration of oral healthcare across care settings.
Local population needs. As a meso level there are local
population issues/demands that impact on the provision of
services in the area. The pharmacy-based oral health intervention
was piloted in parts of County Durham, which has high degrees of
both social and economic deprivation. This study identified that
20% of patients had not visited their dentist in the previous 2
years.17 This represents an opportunity for pharmacy to engage
with patients that are poor dental attenders. Many pharmacist
participants did, however, report significant issues in relation to
their workloads, both at an individual and institutional level.
Therefore, the addition of new services and expansion of roles
needs to be considered in relation to the potential of building
capacity and capability for this level of potential interprofessional
provision (Q7).
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NHS policy and dental care services Q1 The processes of how you get people to take their dental health seriously are very
difficult. The ones that pay for dentistry are likely to be the ones with good teeth, the
others who get free treatment just don’t access it. (GP3)13
Q2 The area I am in is very deprived and actually, I would say that the majority don’t ever
visit the dentist, I think they just don’t see it as important and loads of them just don’t
have the money, and fear, loads of people hate seeing a dentist unless it’s absolutely
necessary. (Pharmacist 5)16
Education of patients and
preconceptions
Q3 I think it [oral health education] would be from my mum and dad and then the dentist. I
don’t think anyone else has ever talked about oral health with me, maybe the school
nurse a long time ago. (Patient 5)16
Q4 I think it’s just the way society has brought us up in that the, there are two defining
people, dentists and doctors. Anything to do with dentists, you go to the dentist.
Anything about your health you go to the doctors. They have always been seen as
separate. (Patient 6)16
Isolation Q5 I think with a lot of things with dentists really, that we are out of the loop, I just don’t
seem to have had much interaction with any other healthcare professionals. (Dentist 6)15
Communication and collaboration Q6 I’m directly contactable face-to-face by prescribers, GPs, nurse practitioners, nurses,
admin team, everything. They can just come directly into my office and ask me for
information. So, I’m probably more likely to be utilised clinically. (Pharmacist 1)16
Local population needs Q7 In that 2min that you have got to hand something out to somebody, you concentrate
on the important things, such as how to take it, to get their concordance and
compliance. (Pharmacist 2)13
Education of healthcare professionals Q8 I personally don’t really feel that I’ve got a good enough understanding of what an
actual pharmacist’s job entails. (Dentist 2)15
Q9 No not really… [we had] a little bit [of shared education] in lectures maybe at university




Q10 I’m in quite an advanced clinical role now. So I do a lot of diagnostics and treating
myself. I’m a prolific prescriber. (Pharmacist 7)16
Professional hierarchies Q11 My clinics could easily be timetabled for 20min instead of 10, and as I don’t really see
acute patients or have the same time pressures as some of the GPs or practice nurses. I
can talk longer and to go into more detail about things, there is scope to take more time
and really reinforce the key messages. (Pharmacist 2)16
Individual clinical competencies Q12 I think most of us know the basics, but not really much depth, especially around how
oral health and just general health and wellbeing are related. (Pharmacist 3)16
Q13 It’s the sort of thing that once you see it, you then remember it [MRONJ]. They were both
very complex patients, but the amount of morbidity involved with the osteonecrosis of
the jaw in both of those patients was considerable. (GP 1)13
Professional relationships Q14 I feel as though the pharmacist that I go to, I could ask her anything and she would tell
us. I have had a review with her, she’s very, very helpful and knowledgeable about
medication. (Patient 5)15
Q15 If you have to wait to get an appointment with the pharmacist at the doctor’s surgery,
you may as well just see the doctor or whatever else. The point of a pharmacist to me it
that it’s, like, around the corner and it’s easy. (Patient 6)16
Isolated working patterns Q16 We don’t seem to engage with dentists. In fact, the only time that I ever had a proper
conversation with a dentist was when I worked in community pharmacy and that would
have been over an incorrect prescription or an out of stock item. And I just think, you
know, there is a lot of cross-conversations that we could have. (Pharmacist 10)16
Q17 I make sure I take medication histories for patients, but they don’t always know exactly
what they take. It’s sometimes hard to be sure the list they give you is accurate.
(Dentist 15)15
Individual patient needs Q18 I think counselling about medication is far better done by the pharmacists. I think the
other reason is perhaps, when a patient sees a doctor they expect to be able to discuss
all aspects of their lives and their care. (GP 1)13
Q19 This is difficult, but mentally, it gives you some kind of anxiety because you- you- you
know your bone is [visible] there- a little piece of [exposed] bone on your left-hand side
is there. (MRONJ Patient 5)14
Q20 Psychological and mental, yeah. If you’re going out to a restaurant, then you have to be
very careful. You don’t want people to see that you are eating awkwardly. (MRONJ
Patient 5)14
Disconnection with general health Q21 I haven’t really heard of links between the two. I see lots of patients with diabetes and it
is definitely not something that I would tell patients about. (Pharmacist 5)16
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Education of healthcare professionals. Pharmacy professionals
had a sound understanding of both their current and potential
future role in oral healthcare provision. However, dental partici-
pants in particular had a limited understanding of what the
pharmacist’s role involved, beyond a transactional approach to the
supply of medication in community pharmacies (Q8). A funda-
mental consideration in relation to the provision of safe and
effective oral healthcare is the limited degree of interprofessional
education within the context of oral health advice. Participants
reported limited interprofessional training with dentists at an
undergraduate level and in practice, resulting in a poor under-
standing of the other professionals’ roles and responsibilities, and
consequently a limited potential to improve holistic patient care
(Q9). As a result, the scope of oral healthcare and the general
competence of individual non-dental professionals in the provi-
sion of oral healthcare is exceptionally limited. Interprofessional
oral health education is clearly also a system (macro) issue and
needs to be an integral part of training programmes in order to
develop both subject-specific knowledge and a greater capacity
for more effective reciprocal and interprofessional collaborations.
Practitioner’s competence and capability. Although not specific to
oral health-related conditions, there is clearly an advancing role
for pharmacists in the delivery of clinical interventions in primary
care. Many of the pharmacists, particularly those working in a
general practice setting, were either working towards, or already
acting as, independent prescribers (Q10). The varying clinical
capability of pharmacists represents differences in the clinical
responsibility and accountability in this professional group, and
therefore the limitations on the care individuals provide at a
micro/clinical level. The roles of individual staff and their potential
to engage in oral healthcare could potentially be enhanced
through upskilling the pharmacy workforce and by further
education. This enhanced role represents an opportunity for
pharmacists, who are the medication experts in the interprofes-
sional team, to take greater responsibility for safe and effective
medication use; this aligns with the safe prescribing and
monitoring of MRONJ-implicated medicines and greater involve-
ment with conditions such as type 2 diabetes as part of chronic
disease management.
Professional hierarchies. Despite the increasing responsibility and
accountability of pharmacy professionals identified above, there
remains a perceived hierarchy from both professionals and
patients, in terms of roles and responsibilities. Pharmacists would
typically report signposting patients for further investigation with
dental and medical issues to either the GDP or GP, respectively.
This clearly represents an appropriate safety net allowing profes-
sionals to practice within the scope of their disciplinary practice
and competence; however, pharmacists identified that they could
potentially contribute more and in many cases are the most
appropriate and accessible professional group to manage simple
oral health issues in the context of primary care (Q11).
Micro (practice integration)
Individual clinical competencies. The limited interprofessional
education on oral health translates at a micro level to a lack of
integration of oral healthcare into the current role of the
pharmacist. Knowledge of oral health issues varied between
individual participants, although most had a workable under-
standing of basic oral health promotion advice (Q12). Participants
identified that a pharmacist’s role includes the promotion of
healthy lifestyles, the provision of preventive advice and the safe
use of medication. However, there were clear gaps in the
knowledge of appropriate preventive strategies for MRONJ in
most participants, and in the wider associations of oral health with
general health and well-being.
Although very few participants had encountered a patient with
MRONJ, the significant quality of life implications associated with
the condition resulted in these individual practitioners being more
vigilant towards the prevention of the condition and the
education of patients at risk of its development (Q13).
Professional relationships. The relationships between pharmacists
and both their patients and other healthcare professionals directly
influence their individual practices. Both pharmacists and patients
reported good reciprocal relationships, with patients highlighting
the ease of access and approachability of their pharmacist, making
them a valued source of health advice (Q14). Patient participants
displayed a positive attitude towards the widening role of
pharmacists and the integration of pharmacists into the general
practice team. There were, however, some concerns regarding the
accessibility of pharmacists in this setting, as a strength of the
traditional community pharmacist is both the convenient location
and accessible working hours (Q15).
Isolated working patterns. A key finding was the perceived
isolation of the dental team from other primary care health
service providers. Although this is clearly an issue at a meso and
macro level as described above, it also results in challenges for the
management of individual patients and for individual practi-
tioners. Participants reported poor collaborative care between
medical and dental services, with limited interprofessional
relationships and a distinct lack of formal referral pathways
(Q16). As a result, participants reported that referrals to dental
teams are typically informal and revolve around the principles of
signposting patients to services, with little or no further follow-up.
The contextual, situational and geographical isolation of dental
professionals reported at an individual level impacts on many





Lack of shared clinical records Q22 It would be brilliant, if we could just see, even just an element of their records, even just
what drugs they were taking. That’s the main thing for us, it takes so long to get the
drug history out of a patient. (Dentist 13)15
Q23 We would never know if the dentists had prescribed any antibiotics or anything for a
patient. Yet, if anyone else in the primary healthcare team prescribes anything for our
patients, we know. (Pharmacist 7)16
Sub-optimal referral pathways Q24 I would say there is anonymity really [between dental and medical service providers]. If
you compare it with, for example, local opticians where we have frequent interactions,
albeit by paper, we don’t really get any, sort of, direct contact. Not that I can recall.
(GP3)16
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accurate medication histories from patients and engaging with
high quality collaborative patient care is a challenge (Q17).
Individual patient needs. Although wider policies and practices at
a meso or macro level can impact on individual patient care, it was
apparent that there are significant variations in individual patient
needs and complexities. Consequently, healthcare practitioners
often have to prioritise the management of certain conditions
and/or the information that is provided to some patients. In many
cases where patients have multiple co-morbidities, oral health was
seen as having a lower priority and therefore was neglected in
preference for matters deemed to be more clinically relevant to
individuals by clinicians (Q18).
Although MRONJ is rare it can have significant negative effects
on patients’ quality of life and the current lack of focus on
preventive strategies at a population-based level is putting
individual patients at risk. The interviews with patients highlighted
the extent of the physical, psychological and social implications of
the conditions that impact significantly on affected individuals.
These include experiencing pain associated with MRONJ, regular
need for analgesic medication, attendance at regular appoint-
ments with medical/dental professionals, concerns about poten-
tial complications and surgical management and social anxieties
linked to eating and drinking in public (Q19, Q20). Greater focus
on preventive care across this patient group could facilitate a
reduction in the incidence of MRONJ.
Functional and normative integration
Disconnection with general health. Oral health was seen by
some participants as being the responsibility of dentists,
with other healthcare professionals and patients not being aware
of, or engaging with, the links between dental and general
health. Education of both healthcare professionals and patients
on the links to general health and well-being could serve to
strengthen the relationship between oral and general
healthcare (Q21).
Lack of shared clinical records. A significant barrier to effective
collaborative oral healthcare is the current lack of access to shared
medical records. Pharmacists have access to Summary Care
Records, but currently GDPs have no access to either full or
Summary Care Records. This was described by participants as a
significant challenge that potentially impacts negatively on
patient safety (Q22).
The safe prevention of MRONJ requires dental practitioners to
be fully informed about a patient’s medication history and access
to this information could improve patient safety, facilitating the
implementation of MRONJ prevention guidelines. Dentists cur-
rently rely on patients to provide medication histories or need to
contact general medical practices directly to obtain the informa-
tion, which is a time-consuming and inefficient process. The
access to shared records can also be a medico-legal issue from the
perspective of medical/pharmacy professionals, as they have no
record of what dental treatment has been performed or which
medication may have been prescribed by GDPs (Q23).
Sub-optimal referral pathways. There is also a distinct lack of
formalised referral pathways between dental and medical care
settings, with participants reporting that referrals were typically
informal and generally based on simply signposting patients
(Q24). As a result, there is no follow-up of patients requiring
referral, no records that referrals have taken place and minimal
communication between care settings. This poses a significant
challenge in the implementation of MRONJ prevention strategies,
which require referrals from prescribers to dentists on prescribing
of implicated medications and, in turn, assurance that patients are
dentally fit to receive these medications before initiation.
Formalised referral pathways, with shared medical records, could
potentially facilitate the implementation of these recommenda-
tion and reduce the incidence of MRONJ in at-risk patients.
DISCUSSION
This study set out to explore the barriers and enablers for
integrating oral healthcare and MRONJ prevention into pharma-
cists’ roles. The critical synthesis of data from five published
papers and alignment to the Rainbow Model for Integrated Care
provided strength and depth not achieved when each paper is
viewed in isolation.
This research reveals that the contextual, situational and
geographical isolation of dental teams is a barrier to optimal
patient care. This is further enhanced by a lack of supportive and
functionally integrative systems; such as no dental access to
patient’s clinical information through full medical or Summary
Care Records. Currently, dentists rely almost exclusively on
patients to provide medical histories, posing a risk to patient
safety; for example, evidence from research on osteoporosis
patients highlighted a perceived lack of awareness of dentists
about patients’ medical conditions with 46.5% of patients
estimating that their dentist was unaware of their diagnosis of
osteoporosis.25 Both dentists and physicians have expressed
agreement that shared records could be useful in practice and
the British Dental Association has previously highlighted that
access to Summary Care Records could improve accuracy of
medical histories and improve antimicrobial stewardship.26,27
The isolated knowledge base and perceived divisions between
the medical and dental professions have been identified
previously in research exploring the collaborative management
of diabetes and identified as a significant contributing factor to
mental illness and burnout amongst dentists.28,29 It was apparent
in our work that there is limited communication between medical
and dental services, with participants reporting a lack of formal
referral pathways. This is similar to research exploring interprofes-
sional collaboration in the context of management of diabetes,
which found that dentists tend not to contact GPs regarding the
management of patients and when they do so it is typically
through the patient, as opposed to formal referral channels.30
Formalising and designating strategic work plans to develop
interprofessional relationships and educational opportunities
could potentially result in higher quality patient care and less
isolation of oral health from general healthcare. On an individual,
clinical level, the significant negative impact of MRONJ on quality
of life has been illuminated through our research. The quality of
life implications of MRONJ have been explored previously in the
literature;31 however, the qualitative methodology adopted in our
work has captured the significant negative impact of the condition
from a human, rather than metric perspective, highlighting the
ongoing challenges and the associated physical, psychological
and social distress. These findings have substantively developed
the evidence base that supports the preventive recommendations
provided in currently established clinical guidelines.12 However,
our research has highlighted that the preventive strategies
recommended in published clinical guidelines are not being
routinely followed in practice.13–15 This poses a question regarding
the potential legal liability of the healthcare team if the
recommended preventive care and associated patient education
are not prioritised. The potential legal implications have previously
been reported, including the finding that malpractice claims have
been made in relation to MRONJ.32
The poor knowledge of oral health amongst pharmacists, GPs
and patients was evident in this work and corresponds with
findings reported in other studies;9,21 this is particularly apparent
in relation to the crossover between oral health and general
health and well-being, representing a focus for targeted educa-
tional initiatives. The introduction of interprofessional education in
oral health could potentially facilitate an improved and reciprocal
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working knowledge that translates into increased implementation
of preventive advice in relation to those medicines associated with
MRONJ and the consequent provision of oral health advice to
identifiably at-risk patients.
We have demonstrated that pharmacists can provide basic oral
health interventions that produce positive intentions to change
oral health behaviours among patients for whom oral health has
not been a priority and who have a history of poor prior
engagement with dental services. The proactive recruitment of
patients to receive oral health interventions is a significant
development in the evidence base, as studies to date have found
that oral health advice is currently only provided by pharmacists in
response to patient requests.8 The expansion of pharmacist’s roles
to incorporate oral healthcare could facilitate an improvement in
oral health in at-risk patient groups. The model designed and
piloted in County Durham could potentially be transferable to
other geographical settings and also represents a novel means of
addressing oral health inequalities in populations that include
poor dental attenders and those with high levels of oral healthcare
intervention and support needs.17
Strengths and limitations
This work is the cumulative synthesis of five individual papers.
Adopting the Rainbow Model for Integrated Care as a theoretical
framework provided both conceptual strength and depth to the
research that is not possible to achieve when viewing each paper
in abstraction from the other published work. All of the research
was performed in the North East of England; a region with
historically poor levels of oral health and challenging socio-
economic demography. In keeping with high quality qualitative
work, the research undertaken is not something from which the
authors seek to generalise findings, but rather highlight transfer-
able findings that can be considered in the context of similar
locations and/or settings. Therefore, the authors fully acknowl-
edge that the application of this work to other regional settings
with differing demographics, or to other settings with differing
dental and/or medical care infrastructure or service models, may
not necessarily be possible. However, there is a clear need for
change across the various levels of the system to support the
integration of oral and general healthcare services.
Implications for practice
At an organisational and professional level, greater consideration
should be given to the incorporation of oral health into locally
commissioned services, designed to meet local population needs.
Services which require closer collaboration between the dental
and medical professions could facilitate a reduction in isolated
practices. Facilitators for functional integration, including the use
of technology to support integrated working, shared medical
records, and formal referral pathways, could improve optimal lines
of communication and patient care.
Pharmacists have the potential to play a significant role in
reducing oral health inequalities and increasing oral health
educational opportunities with patients at high risk of complica-
tions and those with limited prior engagement with dental services.
Interprofessional education not only has the potential to improve
oral health knowledge, but could also improve understanding of
professional roles, break down perceived disciplinary hierarchies
and historically stereotyped roles, and build capacity and capability
in the process. At a systems level there needs to be a greater focus
by regulatory bodies to ensure integration of interprofessional
education and inclusion of oral health education in the initial
training of healthcare professionals and in professional practice.
There is significant need at a systems level to change the oral
health attitudes and behaviours of the population. This could be
facilitated through an NHS dental service that is clearly focused on
prevention and through education of the general public on the
benefits of good oral healthcare, specifically related to the
relationships with general health and well-being. Collaborations
between professional bodies and patient groups could serve to
champion and role model optimal practice and encourage
integration of care.
CONCLUSION
Engaging all professional groups with the links between oral and
general health could potentially facilitate the development of a
collaborative mission to improve the quality and safety of patient
care, and provide tangible benefits for both individual patients
and the wider populations to which they belong. Our research has
shown that pharmacists are currently underutilised in the
provision of oral healthcare and in the prevention of MRONJ.
Pharmacists, working across all settings, are a professional
disciplinary healthcare group that could be utilised effectively to
help address existing oral health inequalities with the ultimate aim
of improving both the quality and safety of patient care in
practice. This requires effective integration across micro, meso and
macro levels of patient care, facilitated through education,
supportive healthcare policies, shared clinical records and
improved lines of communication.
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